| Bioactivity | Anti-inflammatory agent 8 (compound 13) is a tilomisole-based benzimidazothiazole derivative. Anti-inflammatory agent 8 expresses activity on COX-2 enzyme more than COX-1 with an IC50 of 0.09 nM. Anti-inflammatory agent 8 is orally active[1]. |
| Name | Anti-inflammatory agent 8 |
| CAS | 1103920-19-9 |
| Formula | C18H15N5OS2 |
| Molar Mass | 381.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Darwish SA, et al. New tilomisole-based benzimidazothiazole derivatives as anti-inflammatory agents: Synthesis, in vivo, in vitro evaluation, and in silico studies [published online ahead of print, 2022 Jan 29]. Bioorg Chem. 2022;120:105644. |
Anti-inflammatory agent 8
CAS: 1103920-19-9 F: C18H15N5OS2 W: 381.47
Anti-inflammatory agent 8 (compound 13) is a tilomisole-based benzimidazothiazole derivative. Anti-inflammatory agent 8
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.